DM Riche, R Valderrama, NN Henyan - Diabetes Care, 2007 - Am Diabetes Assoc OBJECTIVE—Thiazolidinediones (TZDs) (rosiglitazone and pioglitazone) are a class of antidiabetes
agents that have a high affinity for peroxisome proliferator–activated receptor-γ. TZDs initiate
a multitude of physiologic processes that may elicit benefits as systemic agents for the ... Cited by 26 - Related articles - All 6 versions
ES Rosmarakis, ME Falagas - American Heart Journal, 2007 - Elsevier Five RCTs that included 235 evaluable patients who underwent coronary stent implantation and
received a 6-month pioglitazone or rosiglitazone therapy were included in our
meta-analysis. Restenosis rate was significantly lower in patients who received ... Cited by 21 - Related articles - All 39 versions
CAO Zheng, Z Yu-jie, Z Ying-xin, LIU Yu-yang, GUO … - Chinese medical journal, 2006 - cmj.org Background Recent studies have shown that thiazolidinediones (TZDs) could reduce in-stent
restenosis and improve clinical outcomes in patients with type 2 diabetes after coronary stent
implantation. It remains unclear whether nondiabetic patients with metabolic syndrome ... Cited by 11 - Related articles - Cached - BL Direct - All 6 versions
D Geng, D Jin, W Wu, Z Wang, J Wang - Atherosclerosis, 2009 - Elsevier We performed a meta-analysis of all relevant randomized controlled trials to evaluate the effect
of TZDs therapy on in-stent restenosis in patients undergoing coronary stenting. Eight trials involving
366 patients were included in this study. TZDs therapy was associated with a significant ... Cited by 5 - Related articles - All 29 versions
K Nishio, M Sakurai, T Kusuyama, M Shigemitsu, T … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—A total of 28 patients were randomly assigned to the control group, and 26 patients
were assigned to the pioglitazone group. There were no significant differences in glycemic control
levels or in lipid levels in the two groups at baseline or at follow-up. Insulin, homeostasis ... Cited by 60 - Related articles - BL Direct - All 6 versions
- ►escardiocontent.org DL Bhatt, DP Chew, C Grines, D Mukherjee, M Leesar, … - American Heart Journal, 2007 - Elsevier There was no significant difference in CIMT between the 2 groups. There was no difference in
the 12-month composite end point of death, myocardial infarction (MI), stroke, or any recurrent
ischemia (31.4% vs 30.2%, P = .99). The rate of death, MI, or stroke at 12 months was ... Cited by 15 - Related articles - All 13 versions
A Osman, J Otero, A Brizolara, S Waxman, G Stouffer, … - American Heart Journal, 2004 - Elsevier Patients with treated type 2 diabetes (mean duration 5.5 ± 7.5 years) referred for coronary stenting
were randomized in a double-blind fashion to receive oral rosiglitazone or placebo for 6
months. Quantitative coronary angiography and intravascular ultrasound data were ... Cited by 57 - Related articles - All 8 versions
G Wang, J Wei, Y Guan, N Jin, J Mao, X Wang - Metabolism, 2005 - Elsevier Rosiglitazone, an agonist of peroxisome proliferator–activated receptor-γ (PPARγ), is an
insulin-sensitizing antidiabetic agent and inhibits restenosis in animal blood vessels.
However, its benefit for patients with type 2 diabetes and coronary artery disease (CAD) ... Cited by 44 - Related articles - All 8 versions
T Katayama, H Ueba, K Tsuboi, N Kubo, T Yasu, M … - American Heart Journal, 2007 - Elsevier Twenty-eight nondiabetic patients with MS after bare-metal stent implantation were randomized
to 6-month treatment with or without 30 mg/d of pioglitazone (pioglitazone group [PIO] of 14 patients
with 16 lesions and control group [CONT] of 14 patients with 16 lesions). At baseline and ... Cited by 11 - Related articles - All 27 versions
- ►invasivecardiology.com DJ Kereiakes, JL Petersen, WB Batchelor, PJ … - J Invasive …, 2008 - members.medscape.com The prevalence of diabetes has reached epidemic proportion in many sectors of the world.
[1] Atherosclerotic cardiovascular disease has been correlated with the presence, duration and
severity of diabetes. [2,3] In addition, both clinical and angiographic outcomes following ... Cited by 3 - Related articles - All 9 versions
